Systemic Inflammation As a Driver of Brain Injury: the Astrocyte As an Emerging Player
Overview
Neurology
Authors
Affiliations
Severe systemic inflammation has strong effects on brain functions, promoting permanent neurocognitive dysfunction and high mortality rates. Additionally, hippocampal damage seems to be directly involved in this process and astrocytes play an important role in neuroinflammation and in the neuroimmune response. However, the contribution of the astrocytes to the pathology of acute brain dysfunction is not well understood. Recently, our group established a protocol for obtaining astrocyte cultures from mature brain to allow the characterization of these cells and their functions under pathologic conditions. The present study was designed to characterize astrocyte function after acute systemic inflammation induced by cecal ligation and perforation (CLP). Hippocampal astrocyte cultures from CLP animals presented increased levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, IL-18, and cyclooxygenase-2 and decreased levels of IL-10. This proinflammatory profile was accompanied by an increase in Toll-like receptor (TLR)2 mRNA expression levels and no change either in TLR4 or in vascular endothelial growth factor (VEGF) gene expression. These alterations were associated with increased expressions of p21, nuclear factor kappa B (NFκB), and inducible nitric oxide synthase (iNOS) in astrocytes from CLP animals. The same parameters were also evaluated in whole hippocampal tissue, but differences in this profile were found compared to hippocampal astrocyte cultures from CLP, reflecting an interaction between other central nervous system cell types, which may mask specific astrocytic changes. These results improve our understanding of the mechanisms by which astrocytes react against systemic inflammation, and suggest these cells to be potential targets for therapeutic modulation.
Koehn L, Nguyen K, Tucker R, Lim Y, Chen X, Stonestreet B Mol Neurobiol. 2024; 62(4):5057-5072.
PMID: 39505805 DOI: 10.1007/s12035-024-04594-7.
Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives.
Mohamed W, Kumar J, Alghamdi B, Soliman A, Toshihide Y IBRO Neurosci Rep. 2023; 14:95-110.
PMID: 37388502 PMC: 10300452. DOI: 10.1016/j.ibneur.2022.12.003.
Role of Imaging Modalities and -Acetylcysteine Treatment in Sepsis-Associated Encephalopathy.
Zhong Y, Guan J, Ma Y, Xu M, Cheng Y, Xu L ACS Chem Neurosci. 2023; 14(11):2172-2182.
PMID: 37216423 PMC: 10252850. DOI: 10.1021/acschemneuro.3c00180.
Zhu D, Huang Y, Guo S, Li N, Yang X, Sui A Adv Sci (Weinh). 2023; 10(14):e2205862.
PMID: 36922751 PMC: 10190498. DOI: 10.1002/advs.202205862.
Palandira S, Carrion J, Turecki L, Falvey A, Zeng Q, Liu H Bioelectron Med. 2022; 8(1):18.
PMID: 36451231 PMC: 9710165. DOI: 10.1186/s42234-022-00101-2.